CTLT - CTLT キャタレント ()

CTLTのニュース

   What will the future hold for Catalent Inc. (NYSE:CTLT) stock?  2022/08/31 17:16:00 US Post News
Currently, Catalent Inc.’s (CTLT) stock is trading at $87.96, marking a fall of -1.48% from last night’s close. At this price, the stock is -38.33% below its 52-week high of $142.64 and 1.88% above its 52-week low of $86.34. Based on the past 30-day period, the stock price is -23.00% below the high and +0.31% […]
   Catalent Faces Several Price Target Cuts By Analysts After Q4 Results  2022/08/30 12:36:29 Benzinga
Catalent, Inc. (NYSE: CTLT ) reported mixed results for its fourth quarter on Monday. For FY23, Catalent said it expects $4.975-$5.225 billion in revenue compared to the consensus of $5.26 billion. Catalent shares fell 0.9% to $91.50 in pre-market trading after dropping 7.4% on Monday. Several analysts made changes to their price targets on Catalent … Full story available on Benzinga.com
   Catalent PT Lowered to $110 at Jefferies  2022/08/30 12:10:02 Investing.com
https://www.investing.com/news/pro/catalent-pt-lowered-to-110-at-jefferies-432SI-2882504
   Catalent PT Lowered to $123 at Baird  2022/08/30 10:29:02 Investing.com
https://www.investing.com/news/pro/catalent-pt-lowered-to-123-at-baird-432SI-2882382
   Catalent PT Lowered to $125 at RBC Capital  2022/08/30 10:21:06 Investing.com
https://www.investing.com/news/pro/catalent-pt-lowered-to-125-at-rbc-capital-432SI-2882367
   Novo Holdings A/S Buys 4, Sells 1 in 1st Quarter  2022/05/18 19:00:03 GuruFocus
Related Stocks: CMPI , NKTX , EVO , ASML , CTLT ,
   The Biopharmaceuticals Contract Manufacturing Market to Witness Tremendous Growth with a CAGR of 7.38% During the Study Period (2019-27) | DelveInsight  2022/05/12 17:00:00 Benzinga
New York, USA, May 12, 2022 (GLOBE NEWSWIRE) -- The Biopharmaceuticals Contract Manufacturing Market to Witness Tremendous Growth with a CAGR of 7.38% During the Study Period (2019-27) | DelveInsight As per DelveInsight Analysis in the Biopharmaceuticals Contract Manufacturing market, the demand for contract manufacturing is gaining momentum at present owing to the increase in the investments by the pharmaceutical giants for the research and development of various biologics and biosimilars. Moreover, the advantage of the reduction in overall investment for developing drugs with contract manufacturing is anticipated to raise the adoption of contract manufacturing by biopharma giants in the forthcoming years. According to the latest report published by DelveInsight " Biopharmaceuticals Contract Manufacturing Market Insight " the global Biopharmaceuticals Contract Manufacturing market is projected to witness significant growth owing to the rise in the demand for contract manufacturing by the major biopharmaceutical companies, rising focus on contract manufacturing companies in expanding their capabilities to manufacture biological drugs, presence of robust biologic pipeline among various companies across the globe.
   TFF Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update  2022/05/11 20:01:00 GlobeNewswire
Announced Collaboration with Catalent to Further Expand Thin Film Freezing Applications with a Focus on Biologic Drug Development
   41 Stocks Moving In Tuesday''s Mid-Day Session  2022/05/03 16:14:47 Benzinga
Gainers SoundHound AI, Inc. (NASDAQ: SOUN ) shares jumped 47.4% to $16.13. The company recently completed a SPAC merger deal last week and began trading on Thursday. Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA ) gained 41% to $3.7680 after the company and its partner MicroSafe Group DMCC received EPA approval for Nanocyn as a hospital-grade disinfectant. Ostin Technology Group Co., Ltd. (NASDAQ: OST ) jumped 30.4% to $3.94. Enovix Corporation (NASDAQ: ENVX ) shares gained 29% to $11.52. Enovix announced initial smartwatch battery order from leading global consumer electronics company. Atkore Inc. (NASDAQ: ATKR ) surged 18.1% to $113.81 after the company reported better-than-expected Q2 EPS and sales results. The company also issued Q2 EPS guidance above analyst estimates. TETRA Technologies, Inc. (NYSE: TTI ) gained 17.6% to $4.35. Tetra Technologies recently posted Q1 adjusted EPS of $0.06. Belite Bio, Inc (NASDAQ: BLTE ) jumped 17.3% to $10.41. The FDA has granted Fast Track Designation to Belite Bio’s LBS-008 for Stargardt disease (STGD1).
   Earnings Scheduled For May 3, 2022  2022/05/03 08:52:35 Benzinga
Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ: KNSA ) is projected to report earnings for its first quarter. • Great Lakes Dredge & Dock (NASDAQ: GLDD ) is likely to report quarterly earnings at $0.16 per share on revenue of $170.53 million. • Enel Chile (NYSE: ENIC ) is expected to report quarterly earnings at $82.88 per share on revenue of $994.35 million. • Paramount Global (NASDAQ: PARAA ) is likely to report quarterly earnings at $0.52 per share on revenue of $7.38 billion. • Triton International (NYSE: TRTN ) is likely to report quarterly earnings at $2.63 per share on revenue of $419.07 million. • Colliers Intl Gr (NASDAQ: CIGI ) is likely to report quarterly earnings at $1.59 per share on revenue of $1.14 billion. • Comstock Mining (AMEX: LODE ) is projected to report quarterly loss at $0.03 per share on revenue of $380.00 thousand. • GEO Group (NYSE: GEO ) is expected to report quarterly earnings at $0.22 per share on revenue of $551.47 million. • Kopin (NASDAQ: KOPN ) is expected to report quarterly loss at $0.
   Novo Holdings A/S Buys 4, Sells 1 in 1st Quarter  2022/05/18 19:00:03 GuruFocus
Related Stocks: CMPI , NKTX , EVO , ASML , CTLT ,
   The Biopharmaceuticals Contract Manufacturing Market to Witness Tremendous Growth with a CAGR of 7.38% During the Study Period (2019-27) | DelveInsight  2022/05/12 17:00:00 Benzinga
New York, USA, May 12, 2022 (GLOBE NEWSWIRE) -- The Biopharmaceuticals Contract Manufacturing Market to Witness Tremendous Growth with a CAGR of 7.38% During the Study Period (2019-27) | DelveInsight As per DelveInsight Analysis in the Biopharmaceuticals Contract Manufacturing market, the demand for contract manufacturing is gaining momentum at present owing to the increase in the investments by the pharmaceutical giants for the research and development of various biologics and biosimilars. Moreover, the advantage of the reduction in overall investment for developing drugs with contract manufacturing is anticipated to raise the adoption of contract manufacturing by biopharma giants in the forthcoming years. According to the latest report published by DelveInsight " Biopharmaceuticals Contract Manufacturing Market Insight " the global Biopharmaceuticals Contract Manufacturing market is projected to witness significant growth owing to the rise in the demand for contract manufacturing by the major biopharmaceutical companies, rising focus on contract manufacturing companies in expanding their capabilities to manufacture biological drugs, presence of robust biologic pipeline among various companies across the globe.
   TFF Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update  2022/05/11 20:01:00 GlobeNewswire
Announced Collaboration with Catalent to Further Expand Thin Film Freezing Applications with a Focus on Biologic Drug Development
   41 Stocks Moving In Tuesday''s Mid-Day Session  2022/05/03 16:14:47 Benzinga
Gainers SoundHound AI, Inc. (NASDAQ: SOUN ) shares jumped 47.4% to $16.13. The company recently completed a SPAC merger deal last week and began trading on Thursday. Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA ) gained 41% to $3.7680 after the company and its partner MicroSafe Group DMCC received EPA approval for Nanocyn as a hospital-grade disinfectant. Ostin Technology Group Co., Ltd. (NASDAQ: OST ) jumped 30.4% to $3.94. Enovix Corporation (NASDAQ: ENVX ) shares gained 29% to $11.52. Enovix announced initial smartwatch battery order from leading global consumer electronics company. Atkore Inc. (NASDAQ: ATKR ) surged 18.1% to $113.81 after the company reported better-than-expected Q2 EPS and sales results. The company also issued Q2 EPS guidance above analyst estimates. TETRA Technologies, Inc. (NYSE: TTI ) gained 17.6% to $4.35. Tetra Technologies recently posted Q1 adjusted EPS of $0.06. Belite Bio, Inc (NASDAQ: BLTE ) jumped 17.3% to $10.41. The FDA has granted Fast Track Designation to Belite Bio’s LBS-008 for Stargardt disease (STGD1).
   Earnings Scheduled For May 3, 2022  2022/05/03 08:52:35 Benzinga
Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ: KNSA ) is projected to report earnings for its first quarter. • Great Lakes Dredge & Dock (NASDAQ: GLDD ) is likely to report quarterly earnings at $0.16 per share on revenue of $170.53 million. • Enel Chile (NYSE: ENIC ) is expected to report quarterly earnings at $82.88 per share on revenue of $994.35 million. • Paramount Global (NASDAQ: PARAA ) is likely to report quarterly earnings at $0.52 per share on revenue of $7.38 billion. • Triton International (NYSE: TRTN ) is likely to report quarterly earnings at $2.63 per share on revenue of $419.07 million. • Colliers Intl Gr (NASDAQ: CIGI ) is likely to report quarterly earnings at $1.59 per share on revenue of $1.14 billion. • Comstock Mining (AMEX: LODE ) is projected to report quarterly loss at $0.03 per share on revenue of $380.00 thousand. • GEO Group (NYSE: GEO ) is expected to report quarterly earnings at $0.22 per share on revenue of $551.47 million. • Kopin (NASDAQ: KOPN ) is expected to report quarterly loss at $0.

calendar